Le Lézard
Classified in: Business
Subject: DIV

Ocean Bio-Chem Declares Special Cash Dividend: $0.06 per/share


FORT LAUDERDALE, Fla., March 21, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), announced today that its Board of Directors declared a special cash dividend of $0.06 per share, payable on April 16, 2018 to shareholders of record on April 2, 2018.

"We are very pleased to be able to provide to our shareholders the special cash dividend," said Peter Dornau, Ocean Bio-Chem's President and Chief Executive Officer. "This dividend demonstrates Ocean Bio-Chem's strong financial condition and our continued commitment to increasing shareholder value."

About Ocean Bio-Chem, Inc.:
Ocean Bio-Chem, Inc. is principally engaged in the manufacturing, marketing and distribution of a broad line of appearance and maintenance products for boats, recreational vehicles, automobiles, power sports, outdoor power equipment and motorcycle markets under the Star brite®, StarTron®, Performacide® and other trademarks within the United States and Canada.  In addition, the Company produces private label formulations of many of its products for various customers and provides custom blending and packaging services for these and other products.

The Company trades publicly under NASDAQ Capital Markets, Ticker Symbol: OBCI.

The Company's web sites are: www.oceanbiochem.com, www.starbrite.com, www.startron.com, and www.performacide.com.

Forward-looking Statements:
Certain statements contained in this Press Release constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," or "could," including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from those expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry; reliance on certain key customers; changes in consumer demand for marine, recreational vehicle and automotive products; advertising and promotional efforts; exposure to market risks relating to changes in interest rates, foreign exchange rates, prices for raw materials that are petroleum or chemical based and other factors.

Contact:
Peter Dornau
CEO and President
[email protected]
954-587-6280

Jeff Barocas
Vice President & CFO
[email protected]
954-587-6280

 

SOURCE Ocean Bio-Chem, Inc.


These press releases may also interest you

at 14:50
The Huntington National Bank and its Lift Local Business program have been nationally recognized by the Consumer Bankers Association (CBA) with the 2024 Joe Belew Award. The award honors CBA member banks for their efforts to address pressing social...

at 14:47
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innoviz Technologies Ltd. between April 21, 2021 and February 28, 2023, both dates inclusive (the "Class Period"), of the important May 14, 2024 lead...

at 14:30
Transaction in Own Shares 28 March, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 28 March 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according...

at 14:30
Southwest Airlines Co.  announces the acquisition of SAFFiRE Renewables, LLC (SAFFiRE) as part of the investment portfolio of its wholly owned subsidiary Southwest Airlines Renewable Ventures, LLC (SARV). SARV is dedicated to creating more...

at 14:28
Nuventive, the data-informed improvement companytm, today announced a partnership with D2L, a global learning technology company, to simplify student outcomes analysis and advancement. By linking reports from the D2L Brightspace learning management...

at 14:25
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...



News published on and distributed by: